Search Results - "Forrestal, F"

Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS by Kappos, L, Traboulsee, A, Constantinescu, C, Erälinna, J-P, Forrestal, F, Jongen, P, Pollard, J, Sandberg-Wollheim, M, Sindic, C, Stubinski, B, Uitdehaag, B, Li, D

“…To conduct systematic long-term follow-up (LTFU) of patients in the Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple…”
Get full text

Effects of acute relapses on neuropsychological status in multiple sclerosis patients by Morrow, S. A., Jurgensen, S., Forrestal, F., Munchauer, Frederick E., Benedict, R. H. B.

“…Little is known about neuropsychological status changes in multiple sclerosis (MS) patients experiencing a relapse. The Symbol Digit Modalities Test (SDMT) and…”
Get full text

Canadian treatment optimization recommendations (TOR) as a predictor of disease breakthrough in patients with multiple sclerosis treated with interferon β-1a: analysis of the PRISMS study by Freedman, MS, Forrestal, FG

“…Background Early intervention with an effective disease-modifying drug (DMD) offers the best chance of limiting the inflammatory process that contributes to…”
Get full text

Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks by Morrow, SA, O'Connor, PW, Polman, CH, Goodman, AD, Kappos, L, Lublin, FD, Rudick, RA, Jurgensen, S, Paes, D, Forrestal, F, Benedict, RHB

“…Background and Objectives: Brief cognitive tests to monitor cognitive impairment in patients with multiple sclerosis (MS) are needed. Methods: Performance on…”
Get full text

Ecosystem effects of bluefin tuna Thunnus thynnus thynnus aquaculture in the NW Mediterranean Sea by Forrestal, F, Coll, M, Die, DJ, Christensen, V

“…In recent decades the eastern stock of Atlantic bluefin tuna Thunnus thynnus thynnus has declined, driven by excessive catches partially mediated by the growth…”
Get full text

Canadian treatment optimization recommendations (TOR) as a predictor of disease breakthrough in patients with multiple sclerosis treated with interferon beta-1a: analysis of the PRISMS study by Freedman, M S, Forrestal, F G

“…Early intervention with an effective disease-modifying drug (DMD) offers the best chance of limiting the inflammatory process that contributes to irreversible…”
Get full text

Long-term safety and frequency of repeat zuranolone treatment in patients with major depressive disorder rolling over from the randomised CORAL Study into the open-label SHORELINE Study by Mattingly, G W, Mathew, S J, Parikh, S V, Aaronson, S T, Baune, B T, Czysz, A, Nandy, I, Ona, V, Brown, C, Kyaga, S, restal, F, Levin, S, Doherty, J, Mattingly, G

“…IntroductionZuranolone (ZRN) is a positive allosteric modulator of both synaptic and extrasynaptic gamma-aminobutyric acid type A receptors and a neuroactive…”
Get full text

Predicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer’s Disease by Herring, William L., Gould, Ian Gopal, Fillit, Howard, Lindgren, Peter, Forrestal, Fiona, Thompson, Robin, Pemberton-Ross, Peter

“…Introduction Alzheimer’s disease (AD) is a chronic and progressive neurodegenerative disease that places a substantial burden on patients and caregivers…”
Get full text

Ecosystem effects of bluefin tunaThunnus thynnus thynnusaquaculture in the NW Mediterranean Sea by Forrestal, F., Coll, M., Die, D. J., Christensen, V.

“…In recent decades the eastern stock of Atlantic bluefin tunaThunnus thynnus thynnushas declined, driven by excessive catches partially mediated by the growth…”
Get full text

Erratum to: Effects of acute relapses on neuropsychological status in multiple sclerosis patients by Morrow, S. A., Jurgensen, S., Forrestal, F., Munchauer, Frederick E., Benedict, R. H. B.

Get full text

Long-term subcutaneous interferon beta-la therapy in patients with relapsing-remitting MS by KAPPOS, L, TRABOULSEE, A, UITDEHAAG, B, LI, D, CONSTANTINESCU, C, ERÄLINNA, J.-P, FORRESTAL, F, JONGEN, P, POLLARD, J, SANDBERG-WOLLHEIM, M, SINDIC, C, STUBINSKI, B

“…Objective: To conduct systematic long-term follow-up (LTFU) of patients in the Prevention of Relapses and Disability by Interferon beta-la Subcutaneously in…”
Get full text